Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 31-40 of 231 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2010Perhexiline and hypertrophic cardiomyopathy: A new horizon for metabolic modulationHorowitz, J.; Chirkov, Y.
2009Inhibition of calcifyin nodule formation in cultured porcine aortic valve cells by nitric oxide donorsKennedy, J.; Hua, X.; Mishra, K.; Murphy, G.; Rosenkranz, A.; Horowitz, J.
2013Takotsubo cardiomyopathy after anti-influenza vaccination: catecholaminergic effects of immune systemSingh, K.; Marinelli, T.; Horowitz, J.
2007Clinical Trials Update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITYRecio-Mayoral, A.; Kaski, J.; McMurray, J.; Horowitz, J.; van Veldhuisen, D.; Remme, W.
2007An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: Methodological considerationsHorowitz, J.; Heresztyn, T.
2007PerhexilineAshrafian, H.; Horowitz, J.; Frenneaux, M.
2007Aortic stenosis is associated with elevated plasma levels of asymmetric dimethylarginine (ADMA)Ngo, D.; Heresztyn, T.; Mishra, K.; Marwick, T.; Horowitz, J.
2012Erythropoietin studies should not be abandonedGilutz, H.; Horowitz, J.
2012Pathogenesis of aortic sclerosis: association with low BMI, tissue nitric oxide resistance, but not systemic inflammatory activationSverdlov, A.; Ngo, D.; Horowitz, J.
2012Determinants of aortic sclerosis progression: implications regarding impairment of nitric oxide signalling and potential therapeuticsSverdlov, A.; Ngo, D.; Chan, W.; Chirkov, Y.; Gersh, B.; McNeil, J.; Horowitz, J.